SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer

Pancreas
Juan VazRoland Andersson

Abstract

Pancreatic cancer is a complex and heterogeneous disease that often lacks disease-specific symptoms in early stages. The malignancy is currently the fourth leading cause of cancer-related death in Western countries. In advanced stages, the overall 5-year survival is less than 1% to 2%. Most available treatments lack convincing cost-efficiency determinations and are generally not associated with relevant success rates. Targeting stromal components and stromal depletion is currently becoming an area of extensive research in pancreatic cancer. In this context, a glycoprotein, SPARC (secreted protein acidic and rich in cysteine) appears to play a central role. Still, the role of SPARC in carcinogenesis is controversial because conflicting results have been reported, and the pathways involved in SPARC signaling are not well established. Nonetheless, SPARC is highly expressed in the tumor stroma, principally in peritumoral fibroblasts, and the overexpression of SPARC in this compartment is associated with poorer prognosis. Interestingly, it has been suggested that SPARC present in the tumor stroma could sequester albumin-bound paclitaxel, enhancing the delivery of paclitaxel into the tumor microenvironment. In the present review, we ...Continue Reading

Citations

Oct 1, 2016·BioMed Research International·Javier Martinez-Useros, Jesus Garcia-Foncillas
Mar 7, 2017·Scientific Reports·S YadavalliP Kumar
Oct 27, 2017·International Journal of Molecular Sciences·Naoyoshi Maeda, Katsumi Maenaka
Nov 15, 2017·International Journal of Cancer. Journal International Du Cancer·Otto Phanstiel
Oct 14, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hyunjin ParkHaeryoung Kim
Jun 20, 2018·Chembiochem : a European Journal of Chemical Biology·Pengfei ZhaoYongzhuo Huang
Mar 28, 2017·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Kazuhiro ToyotaTaijiro Sueda
Oct 21, 2016·MedChemComm·Bibiana I FerreiraJames B Lorens
May 15, 2018·The Journal of International Medical Research·Angeliki PapapanagiotouAthanasios G Papavassiliou
Aug 28, 2018·World Journal of Gastrointestinal Oncology·Ozkan Kanat, Hulya Ertas
May 29, 2018·Experimental and Therapeutic Medicine·Hongchao HanAikun Wang
Dec 27, 2016·World Journal of Gastroenterology : WJG·Jing-Ran SuYan-Qing Li
Aug 1, 2020·Frontiers in Bioengineering and Biotechnology·Gennaro SanitàAnnalisa Lamberti
Apr 22, 2017·World Journal of Gastroenterology : WJG·Chandra DiwakarlaDesmond Yip
Dec 15, 2020·Therapeutic Delivery·Mathilde LorscheiderChristophe Chassaing
Sep 6, 2019·Nanomedicine : Nanotechnology, Biology, and Medicine·Hea-Jong ChungSeong-Tshool Hong
Nov 17, 2020·Case Reports in Oncological Medicine·Hoang Quan NguyenDuc Thanh Hoang
Nov 13, 2020·Frontiers in Oncology·Bolun JiangJunchao Guo
Nov 27, 2020·Frontiers in Molecular Biosciences·Changsheng YangLujun Shen
Mar 3, 2020·Cancer Letters·Amanda MunasingheNatasha J Hill
Apr 22, 2021·ACS Applied Materials & Interfaces·Maichi HamaTatsuhiro Ishida
Aug 3, 2021·Frontiers in Oncology·Penelope EdwardsIan Chau
Mar 5, 2017·Advanced Drug Delivery Reviews·Alexandros Marios SofiasChristine Allen
Jan 17, 2019·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·Ughur AghamaliyevKatja Breitkopf-Heinlein

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
xenografts
biopsies

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

American Journal of Therapeutics
Tosaddak Ahmed
Journal of Pediatric Orthopedics. Part B
Shingo HamaKoichi Sairyo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Christina S BaikLaura Q Chow
© 2021 Meta ULC. All rights reserved